Skip to main content
AGMB logo

AGMB · Agomab Therapeutics NV

$12.61 -0.10 (-0.79%)
Market Cap
$617.57M
Shares
49.25M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 33
Total Value: $255,764,559
Total Shares: 23,355,571

Institutional Ownership Trend

2 quarters

Holder Concentration

Across 32 13F filers
Top Holder
22.0%
of institutional value
Top 5
60.2%
of institutional value
Top 10
87.9%
of institutional value
HHI
1,045
Broadly held
Showing 33 of 33
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 2020932 CUSIP 00860C102 13F (30d) 4 filings 4 filers Visit website Investor relations